Derek Chiang
Title
Cited by
Cited by
Year
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network
Nature 455 (7216), 1061, 2008
51962008
Comprehensive molecular characterization of human colon and rectal cancer
Cancer Genome Atlas Network
Nature 487 (7407), 330, 2012
44482012
The landscape of somatic copy-number alteration across human cancers
R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ...
Nature 463 (7283), 899-905, 2010
29132010
Characterizing the cancer genome in lung adenocarcinoma
BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ...
Nature 450 (7171), 893-898, 2007
11292007
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Y Hoshida, A Villanueva, M Kobayashi, J Peix, DY Chiang, A Camargo, ...
New England Journal of Medicine 359 (19), 1995-2004, 2008
11042008
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
JP Koivunen, C Mermel, K Zejnullahu, C Murphy, E Lifshits, AJ Holmes, ...
Clinical Cancer Research 14 (13), 4275-4283, 2008
9982008
MapSplice: accurate mapping of RNA-seq reads for splice junction discovery
K Wang, D Singh, Z Zeng, SJ Coleman, Y Huang, GL Savich, X He, ...
Nucleic acids research 38 (18), e178-e178, 2010
9402010
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma
Y Hoshida, SMB Nijman, M Kobayashi, JA Chan, JP Brunet, DY Chiang, ...
Cancer research 69 (18), 7385-7392, 2009
7042009
Pivotal role of mTOR signaling in hepatocellular carcinoma
A Villanueva, DY Chiang, P Newell, J Peix, S Thung, C Alsinet, V Tovar, ...
Gastroenterology 135 (6), 1972-1983. e11, 2008
6632008
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
H Gao, JM Korn, S Ferretti, JE Monahan, Y Wang, M Singh, C Zhang, ...
Nature medicine 21 (11), 1318-1325, 2015
6362015
Genomics and signaling pathways in hepatocellular carcinoma
A Villanueva, P Newell, DY Chiang, SL Friedman, JM Llovet
Seminars in liver disease 27 (01), 055-076, 2007
5992007
High-resolution mapping of copy-number alterations with massively parallel sequencing
DY Chiang, G Getz, DB Jaffe, MJT O'Kelly, X Zhao, SL Carter, C Russ, ...
Nature methods 6 (1), 99-103, 2009
5712009
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
J Barretina, BS Taylor, S Banerji, AH Ramos, M Lagos-Quintana, ...
Nature genetics 42 (8), 715, 2010
5602010
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
DY Chiang, A Villanueva, Y Hoshida, J Peix, P Newell, B Minguez, ...
Cancer research 68 (16), 6779-6788, 2008
4872008
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression
BK Yoo, L Emdad, Z Su, A Villanueva, DY Chiang, ND Mukhopadhyay, ...
The Journal of clinical investigation 119 (3), 465-477, 2009
3662009
Suppression of lung adenocarcinoma progression by Nkx2-1
MM Winslow, TL Dayton, RGW Verhaak, C Kim-Kiselak, EL Snyder, ...
Nature 473 (7345), 101-104, 2011
3492011
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion
AJ Bass, MS Lawrence, LE Brace, AH Ramos, Y Drier, K Cibulskis, ...
Nature genetics 43 (10), 964-968, 2011
3192011
Predicting drug susceptibility of non–small cell lung cancers based on genetic lesions
ML Sos, K Michel, T Zander, J Weiss, P Frommolt, M Peifer, D Li, R Ullrich, ...
The Journal of clinical investigation 119 (6), 1727-1740, 2009
3012009
Vav2 is an activator of Cdc42, Rac1, and RhoA
K Abe, KL Rossman, B Liu, KD Ritola, D Chiang, SL Campbell, K Burridge, ...
Journal of Biological Chemistry 275 (14), 10141-10149, 2000
2942000
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
P Wang, Q Dong, C Zhang, PF Kuan, Y Liu, WR Jeck, JB Andersen, ...
Oncogene 32 (25), 3091-3100, 2012
2772012
The system can't perform the operation now. Try again later.
Articles 1–20